Clinical Trials Browser

Phase 3 × Interventional × eicosapentaenoic acid ethyl ester × Clear all

NCT03428477 2025-04-18

EMT2

Phase 3 Active not recruiting

Gastrointestinal

Colonic Neoplasms

NCT00146211 2007-12-27

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

Phase 3 Completed

Huntington Disease, Lymphoma, Follicular